aluates Reports

$ 0.0

Automative

Global Solid Tumors Target Proteins Market Research Report 2026

Published Date: 2026-02-05

Report Code: QYRE-Auto-38F17980

Global Solid Tumors Target Proteins Market Research Report 2024

BUY CHAPTERS

Global Solid Tumors Target Proteins Market Research Report 2026

Code: QYRE-Auto-38F17980

Report

2026-02-05

Pages:111

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Kactus Biosystems

Novartis

Kite Pharma

Juno Therapeutics

TargetMol Chemicals

Bio-Techne

ProteoGenix

Creative BioMart

Bio X Cell

Creative-Biolabs

ACROBiosystems

Elabscience

ACRO Biosystems

Sino Biological

Solid Tumors Target Proteins Market

The global Solid Tumors Target Proteins market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Solid tumor target proteins refer to specific proteins present in solid tumors that play a key role in the growth, survival or metastasis of cancer cells. Targeting these proteins can be used to develop therapeutics to specifically intervene in the functions of cancer cells, thereby improving the therapeutic effect and reducing damage to normal cells.

The North American market for Solid Tumors Target Proteins is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Solid Tumors Target Proteins is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Solid Tumors Target Proteins in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Solid Tumors Target Proteins include Kactus Biosystems, Novartis, Kite Pharma, Juno Therapeutics, TargetMol Chemicals, Bio-Techne, ProteoGenix, Creative BioMart, Bio X Cell, Creative Biolabs, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Solid Tumors Target Proteins market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Solid Tumors Target Proteins. The Solid Tumors Target Proteins market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Solid Tumors Target Proteins market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Solid Tumors Target Proteins manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Solid Tumors Target Proteins Market Report

Report Metric	Details
Report Name	Solid Tumors Target Proteins Market
Segment by Type	EGFR Protein HER2 Protein Others
Segment by Application	Hospital Biological Laboratory Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Kactus Biosystems, Novartis, Kite Pharma, Juno Therapeutics, TargetMol Chemicals, Bio-Techne, ProteoGenix, Creative BioMart, Bio X Cell, Creative Biolabs, ACROBiosystems, Elabscience, ACRO Biosystems, Sino Biological
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Solid Tumors Target Proteins companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Solid Tumors Target Proteins Market report?

Ans: The main players in the Solid Tumors Target Proteins Market are Kactus Biosystems, Novartis, Kite Pharma, Juno Therapeutics, TargetMol Chemicals, Bio-Techne, ProteoGenix, Creative BioMart, Bio X Cell, Creative Biolabs, ACROBiosystems, Elabscience, ACRO Biosystems, Sino Biological

What are the Application segmentation covered in the Solid Tumors Target Proteins Market report?

Ans: The Applications covered in the Solid Tumors Target Proteins Market report are Hospital, Biological Laboratory, Others

What are the Type segmentation covered in the Solid Tumors Target Proteins Market report?

Ans: The Types covered in the Solid Tumors Target Proteins Market report are EGFR Protein, HER2 Protein, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Solid Tumors Target Proteins Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 EGFR Protein

1.2.3 HER2 Protein

1.2.4 Others

1.3 Market by Application

1.3.1 Global Solid Tumors Target Proteins Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Biological Laboratory

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Solid Tumors Target Proteins Market Perspective (2021–2032)

2.2 Global Solid Tumors Target Proteins Growth Trends by Region

2.2.1 Global Solid Tumors Target Proteins Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Solid Tumors Target Proteins Historic Market Size by Region (2021–2026)

2.2.3 Solid Tumors Target Proteins Forecasted Market Size by Region (2027–2032)

2.3 Solid Tumors Target Proteins Market Dynamics

2.3.1 Solid Tumors Target Proteins Industry Trends

2.3.2 Solid Tumors Target Proteins Market Drivers

2.3.3 Solid Tumors Target Proteins Market Challenges

2.3.4 Solid Tumors Target Proteins Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Solid Tumors Target Proteins Players by Revenue

3.1.1 Global Top Solid Tumors Target Proteins Players by Revenue (2021–2026)

3.1.2 Global Solid Tumors Target Proteins Revenue Market Share by Players (2021–2026)

3.2 Global Top Solid Tumors Target Proteins Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Solid Tumors Target Proteins Revenue

3.4 Global Solid Tumors Target Proteins Market Concentration Ratio

3.4.1 Global Solid Tumors Target Proteins Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Solid Tumors Target Proteins Revenue in 2025

3.5 Global Key Players of Solid Tumors Target Proteins Head Offices and Areas Served

3.6 Global Key Players of Solid Tumors Target Proteins, Products and Applications

3.7 Global Key Players of Solid Tumors Target Proteins, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Solid Tumors Target Proteins Breakdown Data by Type

4.1 Global Solid Tumors Target Proteins Historic Market Size by Type (2021–2026)

4.2 Global Solid Tumors Target Proteins Forecasted Market Size by Type (2027–2032)

5 Solid Tumors Target Proteins Breakdown Data by Application

5.1 Global Solid Tumors Target Proteins Historic Market Size by Application (2021–2026)

5.2 Global Solid Tumors Target Proteins Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Solid Tumors Target Proteins Market Size (2021–2032)

6.2 North America Solid Tumors Target Proteins Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Solid Tumors Target Proteins Market Size by Country (2021–2026)

6.4 North America Solid Tumors Target Proteins Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Solid Tumors Target Proteins Market Size (2021–2032)

7.2 Europe Solid Tumors Target Proteins Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Solid Tumors Target Proteins Market Size by Country (2021–2026)

7.4 Europe Solid Tumors Target Proteins Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Solid Tumors Target Proteins Market Size (2021–2032)

8.2 Asia-Pacific Solid Tumors Target Proteins Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Solid Tumors Target Proteins Market Size by Region (2021–2026)

8.4 Asia-Pacific Solid Tumors Target Proteins Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Solid Tumors Target Proteins Market Size (2021–2032)

9.2 Latin America Solid Tumors Target Proteins Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Solid Tumors Target Proteins Market Size by Country (2021–2026)

9.4 Latin America Solid Tumors Target Proteins Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Solid Tumors Target Proteins Market Size (2021–2032)

10.2 Middle East & Africa Solid Tumors Target Proteins Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Solid Tumors Target Proteins Market Size by Country (2021–2026)

10.4 Middle East & Africa Solid Tumors Target Proteins Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Kactus Biosystems

11.1.1 Kactus Biosystems Company Details

11.1.2 Kactus Biosystems Business Overview

11.1.3 Kactus Biosystems Solid Tumors Target Proteins Introduction

11.1.4 Kactus Biosystems Revenue in Solid Tumors Target Proteins Business (2021–2026)

11.1.5 Kactus Biosystems Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Solid Tumors Target Proteins Introduction

11.2.4 Novartis Revenue in Solid Tumors Target Proteins Business (2021–2026)

11.2.5 Novartis Recent Development

11.3 Kite Pharma

11.3.1 Kite Pharma Company Details

11.3.2 Kite Pharma Business Overview

11.3.3 Kite Pharma Solid Tumors Target Proteins Introduction

11.3.4 Kite Pharma Revenue in Solid Tumors Target Proteins Business (2021–2026)

11.3.5 Kite Pharma Recent Development

11.4 Juno Therapeutics

11.4.1 Juno Therapeutics Company Details

11.4.2 Juno Therapeutics Business Overview

11.4.3 Juno Therapeutics Solid Tumors Target Proteins Introduction

11.4.4 Juno Therapeutics Revenue in Solid Tumors Target Proteins Business (2021–2026)

11.4.5 Juno Therapeutics Recent Development

11.5 TargetMol Chemicals

11.5.1 TargetMol Chemicals Company Details

11.5.2 TargetMol Chemicals Business Overview

11.5.3 TargetMol Chemicals Solid Tumors Target Proteins Introduction

11.5.4 TargetMol Chemicals Revenue in Solid Tumors Target Proteins Business (2021–2026)

11.5.5 TargetMol Chemicals Recent Development

11.6 Bio-Techne

11.6.1 Bio-Techne Company Details

11.6.2 Bio-Techne Business Overview

11.6.3 Bio-Techne Solid Tumors Target Proteins Introduction

11.6.4 Bio-Techne Revenue in Solid Tumors Target Proteins Business (2021–2026)

11.6.5 Bio-Techne Recent Development

11.7 ProteoGenix

11.7.1 ProteoGenix Company Details

11.7.2 ProteoGenix Business Overview

11.7.3 ProteoGenix Solid Tumors Target Proteins Introduction

11.7.4 ProteoGenix Revenue in Solid Tumors Target Proteins Business (2021–2026)

11.7.5 ProteoGenix Recent Development

11.8 Creative BioMart

11.8.1 Creative BioMart Company Details

11.8.2 Creative BioMart Business Overview

11.8.3 Creative BioMart Solid Tumors Target Proteins Introduction

11.8.4 Creative BioMart Revenue in Solid Tumors Target Proteins Business (2021–2026)

11.8.5 Creative BioMart Recent Development

11.9 Bio X Cell

11.9.1 Bio X Cell Company Details

11.9.2 Bio X Cell Business Overview

11.9.3 Bio X Cell Solid Tumors Target Proteins Introduction

11.9.4 Bio X Cell Revenue in Solid Tumors Target Proteins Business (2021–2026)

11.9.5 Bio X Cell Recent Development

11.10 Creative Biolabs

11.10.1 Creative Biolabs Company Details

11.10.2 Creative Biolabs Business Overview

11.10.3 Creative Biolabs Solid Tumors Target Proteins Introduction

11.10.4 Creative Biolabs Revenue in Solid Tumors Target Proteins Business (2021–2026)

11.10.5 Creative Biolabs Recent Development

11.11 ACROBiosystems

11.11.1 ACROBiosystems Company Details

11.11.2 ACROBiosystems Business Overview

11.11.3 ACROBiosystems Solid Tumors Target Proteins Introduction

11.11.4 ACROBiosystems Revenue in Solid Tumors Target Proteins Business (2021–2026)

11.11.5 ACROBiosystems Recent Development

11.12 Elabscience

11.12.1 Elabscience Company Details

11.12.2 Elabscience Business Overview

11.12.3 Elabscience Solid Tumors Target Proteins Introduction

11.12.4 Elabscience Revenue in Solid Tumors Target Proteins Business (2021–2026)

11.12.5 Elabscience Recent Development

11.13 ACRO Biosystems

11.13.1 ACRO Biosystems Company Details

11.13.2 ACRO Biosystems Business Overview

11.13.3 ACRO Biosystems Solid Tumors Target Proteins Introduction

11.13.4 ACRO Biosystems Revenue in Solid Tumors Target Proteins Business (2021–2026)

11.13.5 ACRO Biosystems Recent Development

11.14 Sino Biological

11.14.1 Sino Biological Company Details

11.14.2 Sino Biological Business Overview

11.14.3 Sino Biological Solid Tumors Target Proteins Introduction

11.14.4 Sino Biological Revenue in Solid Tumors Target Proteins Business (2021–2026)

11.14.5 Sino Biological Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Kactus Biosystems

Novartis

Kite Pharma

Juno Therapeutics

TargetMol Chemicals

Bio-Techne

ProteoGenix

Creative BioMart

Bio X Cell

Creative-Biolabs

ACROBiosystems

Elabscience

ACRO Biosystems

Sino Biological

List of Tables

Table 1. Global Solid Tumors Target Proteins Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of EGFR Protein

Table 3. Key Players of HER2 Protein

Table 4. Key Players of Others

Table 5. Global Solid Tumors Target Proteins Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Solid Tumors Target Proteins Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Solid Tumors Target Proteins Market Size by Region (US$ Million), 2021–2026

Table 8. Global Solid Tumors Target Proteins Market Share by Region (2021–2026)

Table 9. Global Solid Tumors Target Proteins Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Solid Tumors Target Proteins Market Share by Region (2027–2032)

Table 11. Solid Tumors Target Proteins Market Trends

Table 12. Solid Tumors Target Proteins Market Drivers

Table 13. Solid Tumors Target Proteins Market Challenges

Table 14. Solid Tumors Target Proteins Market Restraints

Table 15. Global Solid Tumors Target Proteins Revenue by Players (US$ Million), 2021–2026

Table 16. Global Solid Tumors Target Proteins Market Share by Players (2021–2026)

Table 17. Global Top Solid Tumors Target Proteins Players by Tier (Tier 1, Tier 2, and Tier 3), based on Solid Tumors Target Proteins Revenue, 2025

Table 18. Ranking of Global Top Solid Tumors Target Proteins Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Solid Tumors Target Proteins Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Solid Tumors Target Proteins, Headquarters and Area Served

Table 21. Global Key Players of Solid Tumors Target Proteins, Products and Applications

Table 22. Global Key Players of Solid Tumors Target Proteins, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Solid Tumors Target Proteins Market Size by Type (US$ Million), 2021–2026

Table 25. Global Solid Tumors Target Proteins Revenue Market Share by Type (2021–2026)

Table 26. Global Solid Tumors Target Proteins Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Solid Tumors Target Proteins Revenue Market Share by Type (2027–2032)

Table 28. Global Solid Tumors Target Proteins Market Size by Application (US$ Million), 2021–2026

Table 29. Global Solid Tumors Target Proteins Revenue Market Share by Application (2021–2026)

Table 30. Global Solid Tumors Target Proteins Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Solid Tumors Target Proteins Revenue Market Share by Application (2027–2032)

Table 32. North America Solid Tumors Target Proteins Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Solid Tumors Target Proteins Market Size by Country (US$ Million), 2021–2026

Table 34. North America Solid Tumors Target Proteins Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Solid Tumors Target Proteins Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Solid Tumors Target Proteins Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Solid Tumors Target Proteins Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Solid Tumors Target Proteins Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Solid Tumors Target Proteins Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Solid Tumors Target Proteins Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Solid Tumors Target Proteins Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Solid Tumors Target Proteins Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Solid Tumors Target Proteins Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Solid Tumors Target Proteins Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Solid Tumors Target Proteins Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Solid Tumors Target Proteins Market Size by Country (US$ Million), 2027–2032

Table 47. Kactus Biosystems Company Details

Table 48. Kactus Biosystems Business Overview

Table 49. Kactus Biosystems Solid Tumors Target Proteins Product

Table 50. Kactus Biosystems Revenue in Solid Tumors Target Proteins Business (US$ Million), 2021–2026

Table 51. Kactus Biosystems Recent Development

Table 52. Novartis Company Details

Table 53. Novartis Business Overview

Table 54. Novartis Solid Tumors Target Proteins Product

Table 55. Novartis Revenue in Solid Tumors Target Proteins Business (US$ Million), 2021–2026

Table 56. Novartis Recent Development

Table 57. Kite Pharma Company Details

Table 58. Kite Pharma Business Overview

Table 59. Kite Pharma Solid Tumors Target Proteins Product

Table 60. Kite Pharma Revenue in Solid Tumors Target Proteins Business (US$ Million), 2021–2026

Table 61. Kite Pharma Recent Development

Table 62. Juno Therapeutics Company Details

Table 63. Juno Therapeutics Business Overview

Table 64. Juno Therapeutics Solid Tumors Target Proteins Product

Table 65. Juno Therapeutics Revenue in Solid Tumors Target Proteins Business (US$ Million), 2021–2026

Table 66. Juno Therapeutics Recent Development

Table 67. TargetMol Chemicals Company Details

Table 68. TargetMol Chemicals Business Overview

Table 69. TargetMol Chemicals Solid Tumors Target Proteins Product

Table 70. TargetMol Chemicals Revenue in Solid Tumors Target Proteins Business (US$ Million), 2021–2026

Table 71. TargetMol Chemicals Recent Development

Table 72. Bio-Techne Company Details

Table 73. Bio-Techne Business Overview

Table 74. Bio-Techne Solid Tumors Target Proteins Product

Table 75. Bio-Techne Revenue in Solid Tumors Target Proteins Business (US$ Million), 2021–2026

Table 76. Bio-Techne Recent Development

Table 77. ProteoGenix Company Details

Table 78. ProteoGenix Business Overview

Table 79. ProteoGenix Solid Tumors Target Proteins Product

Table 80. ProteoGenix Revenue in Solid Tumors Target Proteins Business (US$ Million), 2021–2026

Table 81. ProteoGenix Recent Development

Table 82. Creative BioMart Company Details

Table 83. Creative BioMart Business Overview

Table 84. Creative BioMart Solid Tumors Target Proteins Product

Table 85. Creative BioMart Revenue in Solid Tumors Target Proteins Business (US$ Million), 2021–2026

Table 86. Creative BioMart Recent Development

Table 87. Bio X Cell Company Details

Table 88. Bio X Cell Business Overview

Table 89. Bio X Cell Solid Tumors Target Proteins Product

Table 90. Bio X Cell Revenue in Solid Tumors Target Proteins Business (US$ Million), 2021–2026

Table 91. Bio X Cell Recent Development

Table 92. Creative Biolabs Company Details

Table 93. Creative Biolabs Business Overview

Table 94. Creative Biolabs Solid Tumors Target Proteins Product

Table 95. Creative Biolabs Revenue in Solid Tumors Target Proteins Business (US$ Million), 2021–2026

Table 96. Creative Biolabs Recent Development

Table 97. ACROBiosystems Company Details

Table 98. ACROBiosystems Business Overview

Table 99. ACROBiosystems Solid Tumors Target Proteins Product

Table 100. ACROBiosystems Revenue in Solid Tumors Target Proteins Business (US$ Million), 2021–2026

Table 101. ACROBiosystems Recent Development

Table 102. Elabscience Company Details

Table 103. Elabscience Business Overview

Table 104. Elabscience Solid Tumors Target Proteins Product

Table 105. Elabscience Revenue in Solid Tumors Target Proteins Business (US$ Million), 2021–2026

Table 106. Elabscience Recent Development

Table 107. ACRO Biosystems Company Details

Table 108. ACRO Biosystems Business Overview

Table 109. ACRO Biosystems Solid Tumors Target Proteins Product

Table 110. ACRO Biosystems Revenue in Solid Tumors Target Proteins Business (US$ Million), 2021–2026

Table 111. ACRO Biosystems Recent Development

Table 112. Sino Biological Company Details

Table 113. Sino Biological Business Overview

Table 114. Sino Biological Solid Tumors Target Proteins Product

Table 115. Sino Biological Revenue in Solid Tumors Target Proteins Business (US$ Million), 2021–2026

Table 116. Sino Biological Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

Table 120. Authors List of This Report

List of Figures

Figure 1. Solid Tumors Target Proteins Picture

Figure 2. Global Solid Tumors Target Proteins Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Solid Tumors Target Proteins Market Share by Type: 2025 vs 2032

Figure 4. EGFR Protein Features

Figure 5. HER2 Protein Features

Figure 6. Others Features

Figure 7. Global Solid Tumors Target Proteins Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Solid Tumors Target Proteins Market Share by Application: 2025 vs 2032

Figure 9. Hospital Case Studies

Figure 10. Biological Laboratory Case Studies

Figure 11. Others Case Studies

Figure 12. Solid Tumors Target Proteins Report Years Considered

Figure 13. Global Solid Tumors Target Proteins Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Solid Tumors Target Proteins Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Solid Tumors Target Proteins Market Share by Region: 2025 vs 2032

Figure 16. Global Solid Tumors Target Proteins Market Share by Players in 2025

Figure 17. Global Solid Tumors Target Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Solid Tumors Target Proteins Revenue in 2025

Figure 19. North America Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Solid Tumors Target Proteins Market Share by Country (2021–2032)

Figure 21. United States Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Solid Tumors Target Proteins Market Share by Country (2021–2032)

Figure 25. Germany Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Solid Tumors Target Proteins Market Share by Region (2021–2032)

Figure 33. China Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Solid Tumors Target Proteins Market Share by Country (2021–2032)

Figure 41. Mexico Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Solid Tumors Target Proteins Market Share by Country (2021–2032)

Figure 45. Israel Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Solid Tumors Target Proteins Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Kactus Biosystems Revenue Growth Rate in Solid Tumors Target Proteins Business (2021–2026)

Figure 49. Novartis Revenue Growth Rate in Solid Tumors Target Proteins Business (2021–2026)

Figure 50. Kite Pharma Revenue Growth Rate in Solid Tumors Target Proteins Business (2021–2026)

Figure 51. Juno Therapeutics Revenue Growth Rate in Solid Tumors Target Proteins Business (2021–2026)

Figure 52. TargetMol Chemicals Revenue Growth Rate in Solid Tumors Target Proteins Business (2021–2026)

Figure 53. Bio-Techne Revenue Growth Rate in Solid Tumors Target Proteins Business (2021–2026)

Figure 54. ProteoGenix Revenue Growth Rate in Solid Tumors Target Proteins Business (2021–2026)

Figure 55. Creative BioMart Revenue Growth Rate in Solid Tumors Target Proteins Business (2021–2026)

Figure 56. Bio X Cell Revenue Growth Rate in Solid Tumors Target Proteins Business (2021–2026)

Figure 57. Creative Biolabs Revenue Growth Rate in Solid Tumors Target Proteins Business (2021–2026)

Figure 58. ACROBiosystems Revenue Growth Rate in Solid Tumors Target Proteins Business (2021–2026)

Figure 59. Elabscience Revenue Growth Rate in Solid Tumors Target Proteins Business (2021–2026)

Figure 60. ACRO Biosystems Revenue Growth Rate in Solid Tumors Target Proteins Business (2021–2026)

Figure 61. Sino Biological Revenue Growth Rate in Solid Tumors Target Proteins Business (2021–2026)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Targeting Peptides Market Research Report 2024

Global Targeted Antitumor Drugs Market Research Report 2025

Global Bladder Cancer Targeted Drug Market Research Report 2025

Global Targeted Therapy for Bladder Cancer Market Research Report 2025

Global Targeting p53 Cancer Therapies Market Research Report 2024

Global Solid Tumor Therapeutics Market Research Report 2024

Global Cancer Targeted Small Molecule Therapy Market Research Report 2025

Global Immune Checkpoint Proteins Market Research Report 2024

Global Tumor Specific Antigen Market Size Status and Forecast 2019 2025

Global Small Molecule Targeted Cancer Therapy Market Research Report 2025

Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024

Global Targeted Cancer Therapy Market Research Report 2024

Global Molecular Oncology Market Research Report 2024

Global Targeted Small Molecule Therapy Market Research Report 2025

Small Molecule Inhibitors for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Therapeutic Monoclonal Antibodies Market Research Report 2024

Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024

Global Cancer Targeted Drug Market Research Report 2025

Peptide Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions